Pharmaceutical Care Program for Type 2 Diabetes Mellitus
NCT ID: NCT02435693
Last Updated: 2015-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
600 participants
INTERVENTIONAL
2012-07-31
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives:-
1. To evaluate Pharmaceutical care program in Type2 diabetics.
2. To evaluate the impacts of Pharmaceutical care on quality of life (QOL) in patient with Type-2 Diabetes Mellitus.
3. To study the prevalence of Type2 diabetics cases in Dhule.
4. To study the Assessment of different type of adverse drug reactions (ADRs). In Type2 diabetics.
5. To evaluate the Drug Drug intereaction in Type-2 Diabetes Mellitus.
6. To study the impacts of Pharmaceutical care program on glycemic control in patients with Type-2 Diabetes Mellitus.
7. To study the Drug utilization pattern in Type-2 Diabetes Mellitus in civil hospital Dhule.
8. To compare the efficiency of Pharmaceutical care program and drug in patients with Type-2 Diabetes Mellitus.
9. To study the Pharmaco-economic evaluation in Type-2 Diabetes Mellitus patient's.
10. To increase the patient compliance and positive attitude of patients towards the diabetes disease by counseling.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diabetes Care Programme for Type 2 Diabetes Mellitus in Primary Care Setting
NCT04348565
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India
NCT01351922
A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Indonesia
NCT01934686
Collaborative Care Model on Type 2 Diabetic Patients
NCT03553862
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Singapore
NCT00836030
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To study the prevalence of Type2 diabetics cases in Dhule. To study the Assessment of different type of adverse drug reactions (ADRs). In Type2 diabetics.
To evaluate the Drug Drug intereaction in Type-2 Diabetes Mellitus.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PHARMACEUTICAL CARE programe
The pharmaceutical care program was characterized by face to face monthly visits to collect information, register information, prepare plan of care for every health problem; identification of drug therapy problems, communication to prescribers the drug therapy problems identified and education of participants to resolve the drug therapy problems.
PHARMACEUTICAL CARE programe
The pharmaceutical care program was characterized by face to face monthly visits to collect information, register information, prepare plan of care for every health problem; identification of drug therapy problems, communication to prescribers the drug therapy problems identified and education of participants to resolve the drug therapy problems.
control
without pharmaceutical care programe (control)
Without PHARMACEUTICAL CARE programe
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PHARMACEUTICAL CARE programe
The pharmaceutical care program was characterized by face to face monthly visits to collect information, register information, prepare plan of care for every health problem; identification of drug therapy problems, communication to prescribers the drug therapy problems identified and education of participants to resolve the drug therapy problems.
Without PHARMACEUTICAL CARE programe
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with HbA1c more than 7% and
* Patients with blood sugar level more than 140 mg / dl
Exclusion Criteria
* Patient with heart failure.
* Patient with chronic Diabetes problem and orthopedic problem
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TABREJ MUJAWAR
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
TABREJ MUJAWAR
tabrej mujawar mpharm Study principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
tabrej aj mujawar, mpharm
Role: PRINCIPAL_INVESTIGATOR
muhs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tabrej Aj Mujawar
Dhule, Maharashtra, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
pc
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.